DoW Traumatic Brain Injury and Psychological Health, Translational Research Award

The DoD Traumatic Brain Injury and Psychological Health, Translational Research Award is a forecasted federal funding opportunity administered by the Department of Defense through the U.S. Army Medical Research Acquisition Activity under the Military Medical Research and Development Assistance Listing 12.420. The opportunity is part of the Traumatic Brain Injury and Psychological Health Research Program and is intended to support translational research efforts that accelerate the movement of scientific discoveries into clinically meaningful applications. The program specifically emphasizes innovation and advancement toward practical clinical impact rather than incremental modifications to existing standards of care. According to the notice, applications that merely propose small iterative changes without a meaningful likelihood of improving patient outcomes or clinical care are considered outside the intent of the mechanism. The award mechanism is structured to support translational activities that bridge the gap between scientific findings and future human application. Basic research activities and clinical trials are expressly prohibited under this opportunity, signaling that the program seeks mature concepts supported by preliminary data and positioned for translational advancement. Applicants are required to provide preliminary data demonstrating feasibility and readiness for further development. The funding opportunity also requires that animal studies include a clear justification for the selected model and a description of how that model relates to the human clinical condition being addressed. For projects involving prospective enrollment of human subjects, the inclusion of community-based participatory research approaches is mandatory, demonstrating the program’s emphasis on patient-centered and community-engaged translational science. The Translational Research Award offers two distinct research levels that applicants must select from based on the maturity and scope of the proposed work. Research Level 1 is intended to support the refinement of mature concepts into tangible or knowledge products that are ready for additional evaluation. Research Level 2 is designed to support rigorous evaluation activities intended to prepare products for first-in-human studies or future clinical trials. While the opportunity does not provide award ceiling or floor amounts within the forecast notice, the estimated total program funding is stated as $9,000,000 with an anticipated six awards. The funding announcement does not identify any matching or cost-sharing requirements, and the opportunity explicitly indicates that no cost sharing or matching is required for applicants. The funding opportunity also contains an Early-Career Investigator Partnering Option that is available under both research levels. This option permits two Principal Investigators to participate jointly, provided that one of the investigators qualifies as an Early-Career Investigator. If selected for funding, each Principal Investigator under this arrangement will receive a separate award. This structure is intended to promote mentorship, workforce development, and the advancement of emerging researchers within the traumatic brain injury and psychological health research community. The opportunity is open to unrestricted applicants, although additional eligibility clarifications may later appear in the full announcement materials when released. The opportunity is currently in forecast status on Grants.gov. The forecast notice was posted on May 6, 2026, and the estimated posting date for the complete application package is June 15, 2026. The estimated application due date is October 15, 2026, and anticipated awards and project start dates are both listed as September 30, 2027. Because the opportunity has not yet officially opened, applicants are currently in an early engagement phase and should monitor the official Congressionally Directed Medical Research Programs website and Grants.gov for release of the full funding announcement and application instructions. The notice does not identify a letter of intent, concept paper, or other pre-application requirement at this stage. The funding opportunity falls within the federal Science and Technology and other Research and Development category and supports translational biomedical and behavioral health research relevant to military and veteran populations affected by traumatic brain injury and psychological health conditions. The opportunity appears to be part of an annually recurring Department of Defense medical research funding portfolio, as evidenced by the fiscal year designation and linked pre-announcement materials. Interested applicants are directed to the official program pre-announcement page hosted by the Congressionally Directed Medical Research Programs at https://cdmrp.health.mil/pubs/press/2026/tbiphrppreann. Questions regarding electronic submission systems and application support may be directed to the eBRAP Help Desk at help@eBRAP.org or by phone at 301-682-5507.

Focus on innovative translational approaches with strong potential to improve clinical care or patient outcomes. Avoid incremental modifications to existing standards without meaningful clinical advancement potential. Clearly justify translational relevance, demonstrate maturity through preliminary data, and align animal or human subject methodologies with intended clinical application.